UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer Journal article
Lin,Ziyou, Li,Jingwei, Zhang,Jian, Feng,Weineng, Lu,Jiaye, Ma,Xiaofan, Ding,Wen, Ouyang,Shumin, Lu,Jinjian, Yue,Peibin, Wan,Guohui, Liu,Peiqing, Zhang,Xiaolei. Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer[J]. Cancer research, 2023, 83(13), 2187-2207.
Authors:  Lin,Ziyou;  Li,Jingwei;  Zhang,Jian;  Feng,Weineng;  Lu,Jiaye; et al.
Favorite | TC[WOS]:32 TC[Scopus]:31  IF:12.5/11.6 | Submit date:2023/08/03
Identification of disulfide isomerase ERp57 as a target for small molecule cardioprotective agents Journal article
Guozhen Cui, Luchen Shan, Ivan Keung Chu, Guohui Li, George Pak Heng Leung, Yuqiang Wang, Yiu Wa KWAN, Shun Wan CHAN, Maggie Pui Man Hoi, Simon Ming Yuen Lee. Identification of disulfide isomerase ERp57 as a target for small molecule cardioprotective agents[J]. RSC Advances, 2015, 5(91), 74605-74610.
Authors:  Guozhen Cui;  Luchen Shan;  Ivan Keung Chu;  Guohui Li;  George Pak Heng Leung; et al.
Favorite | TC[WOS]:11 TC[Scopus]:14  IF:3.9/3.9 | Submit date:2018/11/06